Search Results for "Buprenorphine Lc Ms Ms Method"

06:55 EDT 27th October 2016 | BioPortfolio

Matching Channels


Fluorescent in situ hybridization (FISH) is a sensitive and accurate technique that allows the detection of chromosome aberrations. In this method, a single-stranded fluorescent-labeled nucleic acid...

Spirometry Test

The gold standard in lung testing In the same way that blood pressure measurements provide a simple yet effective screening method for cardiovascular disease, spirometry tests can help to unmask t...

Herpes simplex virus HSV 1 HSV 2 HHV 1 HHV 2

Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 (HHV-1 and -2), are two members of the herpes virus family that infect humans. HSV-1 and HSV-2 cause the vira...

Breast Implants - Augmentation

Breast implants are medical devices that are used to augment breast size or to reconstruct the breast following mastectomy or to correct a congenital abnormality. Breast implants consist of a silico...


ImuXen® is a liposomal technology platform designed to improve the delivery and effectiveness of DNA, protein and polysaccharide vaccines. Proof of concept preclinical studies with a number of...

Matching News

Buprenorphine Implant May Boost Opioid Abstinence

More opioid-dependent patients whose conditions were stabilized with sublingual buprenorphine maintained abstinence over 6 months when switching to buprenorphine implants. Medscape Medical News

The First-Ever FDA-Approved Buprenorphine Implant For Opioid Dependence

The Food and Drug Administration this week approved the first buprenorphine implant for the treatment of opioid dependence. Designed to provide a low-level dose of buprenorphine—a drug commonly used...

Opioid addiction treatment continues to grab headlines

An article in the latest issue of Guernica, a magazine of art and politics, details the plight of doctors prescribing buprenorphine, a medication for the treatment of opiate addiction. Unlike methadon...

US FDA approves first buprenorphine implant for treatment of opioid dependence

The US Food and Drug Administration (FDA) approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a constant, low─l...

Buprenorphine Implants for Opioid Dependence Among Abstinent Adults

This noninferiority trial compares the effects of implanted vs sublingual buprenorphine for sustaining abstinence among adults with opioid dependence who achieved abstinence after 6 months or more of ...

Physician Capacity to Provide Buprenorphine-Assisted Treatment for Opioid Overuse

Many physicians with waivers to prescribe buprenorphine are treating only a small number of patients.

JAMA article points to effectiveness of Titan’s buprenorphine implant

A randomized clinical trial reported in the current online issue of the Journal of the American Medical Association found that Titan Pharmaceuticals’ (NASDAQ:TTNP) six-month buprenorphine implant, k...

FDA Approves Probuphine (buprenorphine) Implant for Treatment of Opioid Dependence

May 26, 2016 -- The U.S. Food and Drug Administration today approved Probuphine, the first buprenorphine implant for the maintenance treatment of opioid dependence. Probuphine is designed to provide a...

Matching PubMed Articles

Predictors of neonatal abstinence syndrome in buprenorphine exposed newborn: can cord blood buprenorphine metabolite levels help?

Buprenorphine is a semi-synthetic opioid used for the treatment of opioid dependence. Opioid use, including buprenorphine, has been increasing in recent years, in the general population and in pregnan...

Effect of Buprenorphine Implants on Illicit Opioid Use Among Abstinent Adults With Opioid Dependence Treated With Sublingual Buprenorphine: A Randomized Clinical Trial.

The effectiveness of buprenorphine treatment of opioid dependence is limited by suboptimal medication adherence, abuse, and diversion.

A novel approach in the detoxification of intravenous buprenorphine dependence.

Opioid dependence remains a significant problem in India, and of late intravenous (IV) buprenorphine use has increased in India, especially in combination with antihistamines and benzodiazepines. Its ...

Occurrence of peripheral edema in a switch from buprenorphine alone to the buprenorphine-naloxone combination: About one case.

Mediation of buprenorphine analgesia by a combination of traditional and truncated mu opioid receptor splice variants.

Buprenorphine has long been classified as a mu analgesic, although its high affinity for other opioid receptor classes and the orphanin FQ/nociceptin ORL1 receptor may contribute to its other actions....

Search Whole site using Google

Quick Search
Advertisement Advertisement